Keywords: Parkinson's Disease, Diffusion Tensor ImagingThe present study systematically and comprehensively reviewed the axonal pathways projecting from the deep brain nuclei that are emerging targets for treating Parkinson’s disease (PD). We tracked 124 deep brain nuclear pathways across different neurotransmitters systems in the high angular HCP-1065 diffusion MRI template using diffusion MRI tractography. With the trajectories of these pathways, we successfully used Parkinson's Progression Markers Initiative (PPMI) diffusion tensor imaging (DTI) data to characterize abnormal DTI changes in noradrenergic and serotoninergic pathways in relation to the severity of non-motor symptoms in de novo PD patients, suggesting a wide neural involvement of clinical PD manifestations.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords